Lazard Asset Management
AGN

Lazard Asset Management’s Allergan Inc AGN Stock Holding History

Lazard Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-7,643
Closed -$1.62M – 1273
2014
Q4 		$1.62M Sell
7,643
-6,005
-44% -$1.19M ﹤0.01% 699
2014
Q3 		$2.43M Buy
13,648
+1,600
+13% +$266K 0.01% 604
2014
Q2 		$2.04M Sell
12,048
-2,570
-18% -$400K ﹤0.01% 645
2014
Q1 		$1.81M Buy
14,618
+14,018
+2,336% +$1.71M ﹤0.01% 612
2013
Q4 		$66K Hold
600
– – ﹤0.01% 894
2013
Q3 		$54K Hold
600
– – ﹤0.01% 861
2013
Q2 		$50K Buy
+600
New +$62.2K ﹤0.01% 913

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Lazard Asset Management's AGN Position: Q1 2015 in Review

Lazard Asset Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 7,643 shares — an estimated $1.62M sold.

Lazard Asset Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $2.43M in Q3 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Lazard Asset Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Lazard Asset Management sold 7,643 Allergan Inc shares in Q1 2015, an estimated $1.62M.
  • Lazard Asset Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Lazard Asset Management's Allergan Inc position peaked at $2.43M in Q3 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Lazard Asset Management's 13F filing for Q1 2015, filed 15 May 2015.